COPY NUMBER SIGNATURE OF RECURRENT GENE FUSIONS REVEALS POTENTIAL DRUG TARGETS IN INVASIVE BREAST CANCER

$409,693FY2012Department of the ArmyDOD

Baylor College Of Medicine, Houston TX

Investigators

COPY NUMBER SIGNATURE OF RECURRENT GENE FUSIONS REVEALS POTENTIAL DRUG TARGETS IN INVASIVE BREAST CANCER · GrantIndex